Get notified when AMST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Concurrent Private Placement of Pre-funded Warrants and Series A-1/a-2 Warrants For Up to 3,623,700 Shares (new) — The warrant-heavy private placement creates substantial potential dilution well beyond the 696,866 primary shares, with exercise prices as low as $0.001.
- Immediate Dilution of $1.09 Per Share (new) — New investors pay $1.435 per share while net tangible book value is only $0.21 per share, resulting in immediate and substantial dilution.
- Nasdaq Listing Risk (new) — The company explicitly warns it may not be able to maintain Nasdaq listing requirements, which could reduce liquidity and impair financing.
Amesite prices $1.0M offering of 696,866 shares at $1.435, with concurrent warrant-heavy private placement
Filed April 28, 2026 · ~1 min read
Key Changes
-
high
Amesite is selling 696,866 shares at $1.435 per share for gross proceeds of about $1.0 million before fees.
The Offering verify on EDGAR → -
medium
The company will use net proceeds for general corporate and working capital purposes, with no specific projects identified.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $1.09 per share, as net tangible book value is only $0.21 per share before the offering.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Partner
Trade AMST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify